DEBORAH MCLANAHAN: Open Payments
NPI 1417921503 · SELLERSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,384 in 104 payments from 13 companies in 2025. Trend: 2023 $2,681 · 2024 $3,672 · 2025 $2,384
Food & beverage: $2,168Education: $216
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 48 | $1,019 |
| Regeneron Healthcare Solutions, Inc. | 10 | $426 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $305 |
| ABBVIE INC. | 20 | $279 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| Amgen Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $29 |
| Verrica Pharmaceuticals Inc. | 1 | $27 |
| Galderma Laboratories, L.P. | 1 | $23 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, ILUMYA, RINVOQ, Sotyktu, OTEZLA, Odomzo.
Industry payments across PA — which companies pay providers there.
